|
421 |
Oral Therapies for Multiple Sclerosis
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 1, date:1.2011: 37-52
|
|
|
|
422 |
Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza
Enthalten in Clinical pharmacokinetics Bd. 49, 30.9.2012, Nr. 11, date:11.2010: 741-765
|
|
|
|
423 |
Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses
Enthalten in Drugs Bd. 69, 17.9.2012, Nr. 18, date:12.2009: 2523-2531
|
|
|
|
424 |
Overcoming Treatment Resistance in HER2-Positive Breast Cancer
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 9, date:9.2012: 1175-1193
|
|
|
|
425 |
Overview of Venous Thromboembolism
Enthalten in Drugs Bd. 70, 12.12.2012, Nr. 2, date:12.2010: 3-10
|
|
|
|
426 |
Pain Alleviation and Patient-Reported Health Outcomes following Switching to Pregabalin in Individuals with Gabapentin-Refractory Neuropathic Pain in Routine Medical Practice
Enthalten in Clinical drug investigation Bd. 32, 13.12.2012, Nr. 6, date:6.2012: 401-412
|
|
|
|
427 |
Pain Freedom at 2 Hours in Migraine after Telcagepant 300 mg
Enthalten in CNS drugs Bd. 25, 1.3.2011, Nr. 3, date:3.2011: 269-270
|
|
|
|
428 |
Patient Advocacy in Research
Enthalten in The Patient Bd. 4, 24.8.2012, Nr. 2, date:6.2011: 69-71
|
|
|
|
429 |
Patient Preferences for Community Pharmacy Asthma Services
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 961-976
|
|
|
|
430 |
Patient-Reported Outcomes in Rheumatoid Arthritis
Enthalten in The Patient Bd. 3, 24.8.2012, Nr. 3, date:9.2010: 133-143
|
|
Administration
